ING Group’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.67M | Buy |
17,294
+1,938
| +13% | +$380K | 0.02% | 349 |
|
|
2026
Q1 | $3.01M | Sell |
15,356
-1,753
| -10% | -$341K | 0.02% | 322 |
|
|
2025
Q4 | $2.97M | Buy |
17,109
+461
| +3% | +$83.9K | 0.02% | 340 |
|
|
2025
Q3 | $3.17M | Buy |
+16,648
| New | +$2.95M | 0.02% | 333 |
|
|
2025
Q2 | – | Sell |
-13,074
| Closed | -$2.21M | – | 501 |
|
|
2025
Q1 | $2.21M | Buy |
13,074
+2,764
| +27% | +$454K | 0.02% | 322 |
|
|
2024
Q4 | $1.56M | Sell |
10,310
-33,477
| -76% | -$5.21M | 0.01% | 448 |
|
|
2024
Q3 | $6.8M | Buy |
43,787
+4,340
| +11% | +$648K | 0.04% | 250 |
|
|
2024
Q2 | $5.4M | Sell |
39,447
-43,609
| -53% | -$5.97M | 0.03% | 310 |
|
|
2024
Q1 | $11.1M | Buy |
83,056
+76,163
| +1,105% | +$9.88M | 0.08% | 217 |
|
|
2023
Q4 | $950K | Sell |
6,893
-6,897
| -50% | -$907K | 0.01% | 488 |
|
|
2023
Q3 | $1.68M | Buy |
+13,790
| New | +$1.84M | 0.01% | 394 |
|
|
2023
Q2 | – | Sell |
-18,862
| Closed | -$2.67M | – | 575 |
|
|
2023
Q1 | $2.67M | Buy |
18,862
+3,698
| +24% | +$529K | 0.03% | 331 |
|
|
2022
Q4 | $2.37M | Buy |
15,164
+10,888
| +255% | +$1.56M | 0.02% | 335 |
|
|
2022
Q3 | $525K | Sell |
4,276
-17,810
| -81% | -$2.35M | 0.01% | 379 |
|
|
2022
Q2 | $2.94M | Buy |
22,086
+20,206
| +1,075% | +$2.75M | 0.03% | 333 |
|
|
2022
Q1 | $257K | Sell |
1,880
-14,131
| -88% | -$1.97M | ﹤0.01% | 513 |
|
|
2021
Q4 | $2.77M | Buy |
16,011
+5,753
| +56% | +$875K | 0.02% | 408 |
|
|
2021
Q3 | $1.49M | Buy |
+10,258
| New | +$1.5M | 0.02% | 432 |
|
|
2021
Q2 | – | Sell |
-8,836
| Closed | -$1.13M | – | 561 |
|
|
2021
Q1 | $1.13M | Sell |
8,836
-103
| -1% | -$12.7K | 0.02% | 362 |
|
|
2020
Q4 | $1.06M | Buy |
8,939
+5,967
| +201% | +$727K | 0.02% | 374 |
|
|
2020
Q3 | $340K | Buy |
+2,972
| New | +$351K | 0.01% | 367 |
|
|
2020
Q1 | – | Sell |
-9,239
| Closed | -$987K | – | 427 |
|
|
2019
Q4 | $987K | Buy |
9,239
+835
| +10% | +$87.1K | 0.03% | 304 |
|
|
2019
Q3 | $899K | Sell |
8,404
-11,694
| -58% | -$1.2M | 0.02% | 319 |
|
|
2019
Q2 | $2.05M | Buy |
20,098
+101
| +0.5% | +$9.71K | 0.04% | 262 |
|
|
2019
Q1 | $1.8M | Buy |
+19,997
| New | +$1.73M | 0.04% | 230 |
|
|
2018
Q4 | – | Sell |
-29,627
| Closed | -$3.2M | – | 733 |
|
|
2018
Q3 | $3.2M | Buy |
29,627
+15,085
| +104% | +$1.65M | 0.06% | 208 |
|
|
2018
Q2 | $1.6M | Buy |
14,542
+683
| +5% | +$71.2K | 0.03% | 247 |
|
|
2018
Q1 | $1.39M | Buy |
13,859
+899
| +7% | +$92.1K | 0.03% | 270 |
|
|
2017
Q4 | $1.28M | Buy |
12,960
+8,162
| +170% | +$774K | 0.02% | 289 |
|
|
2017
Q3 | $449K | Buy |
+4,798
| New | +$509K | 0.01% | 526 |
|
|
2017
Q2 | – | Sell |
-10,696
| Closed | -$1.05M | – | 849 |
|
|
2017
Q1 | $1.05M | Sell |
10,696
-981
| -8% | -$93.5K | 0.02% | 334 |
|
|
2016
Q4 | $1.07M | Buy |
11,677
+2,820
| +32% | +$243K | 0.02% | 306 |
|
|
2016
Q3 | $740K | Buy |
8,857
+3,824
| +76% | +$321K | 0.01% | 329 |
|
|
2016
Q2 | $410K | Buy |
5,033
+1,787
| +55% | +$136K | 0.01% | 375 |
|
|
2016
Q1 | $232K | Sell |
3,246
-186,296
| -98% | -$12.5M | ﹤0.01% | 495 |
|
|
2015
Q4 | $13.5M | Sell |
189,542
-7,700
| -4% | -$518K | 0.08% | 202 |
|
|
2015
Q3 | $12.1M | Sell |
197,242
-133,900
| -40% | -$9.36M | 0.08% | 181 |
|
|
2015
Q2 | $24M | Sell |
331,142
-111,320
| -25% | -$8.22M | 0.13% | 154 |
|
|
2015
Q1 | $34M | Sell |
442,462
-127,950
| -22% | -$9.16M | 0.17% | 134 |
|
|
2014
Q4 | $38.3M | Sell |
570,412
-94,030
| -14% | -$5.93M | 0.18% | 121 |
|
|
2014
Q3 | $40.3M | Buy |
664,442
+22,000
| +3% | +$1.36M | 0.23% | 103 |
|
|
2014
Q2 | $37.7M | Sell |
642,442
-81,400
| -11% | -$4.77M | 0.19% | 114 |
|
|
2014
Q1 | $41.9M | Sell |
723,842
-48,958
| -6% | -$2.62M | 0.22% | 112 |
|
|
2013
Q4 | $41.4M | Buy |
772,800
+298,800
| +63% | +$17.7M | 0.21% | 119 |
|
|
2013
Q3 | $29.3M | Buy |
474,000
+108,000
| +30% | +$6.46M | 0.15% | 153 |
|
|
2013
Q2 | $22.2M | Buy |
+366,000
| New | +$21.8M | 0.12% | 187 |
|
Other funds holding DGX
EIG
ING Group's DGX Position: Q2 2026 in Review
ING Group increased its Quest Diagnostics (DGX) stake by 13% in Q2 2026, buying an estimated $380K and bringing the position to 17,294 shares worth $3.67M. The position accounts for 0.02% of the portfolio, ranked #349.
ING Group first reported a position in DGX in Q2 2013 and has held it in 46 quarters since. The position peaked at $41.9M in Q1 2014. 1,105 funds tracked by Wall St. Rank hold DGX as of Q2 2026.
- ING Group held 17,294 shares of Quest Diagnostics worth $3.67M as of Q2 2026.
- ING Group bought 1,938 Quest Diagnostics shares in Q2 2026, an estimated $380K.
- Quest Diagnostics made up 0.02% of ING Group's portfolio in Q2 2026, its #349 holding.
- ING Group first reported a position in Quest Diagnostics in Q2 2013 and has held it in 46 quarters since.
- ING Group's Quest Diagnostics position peaked at $41.9M in Q1 2014.
- 1,105 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.
Based on ING Group's 13F filing for Q2 2026, filed 13 Aug 2026.